Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and Mydriasis

quinoxalines has been researched along with Mydriasis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campagna, O; Colica, C; Cruciani, F; De Vico, U; Gharbiya, M1
Brown, SM; Khanani, AM; McCartney, DL1
García-Sevilla, JA; Garro, MA; Giralt, MT; Menargues, A; Miralles, A; Obach, R; Olmos, G; Pineda, J; Ugedo, L1
Hashimoto, A; Imaizumi, T; Kambe, T; Kishi, M; Mori, T; Nakazawa, T; Orito, K1

Other Studies

4 other study(ies) available for quinoxalines and Mydriasis

ArticleYear
Urrets- Zavalia Syndrome after glaucoma filtration device implantation.
    La Clinica terapeutica, 2013, Volume: 164, Issue:5

    Topics: Acetazolamide; Aged; Brimonidine Tartrate; Cataract Extraction; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Hypertension; Miotics; Mydriasis; Ocular Hypertension; Pilocarpine; Prostaglandins F; Quinoxalines; Sulfonamides; Syndrome; Thiophenes; Timolol

2013
The effect of daily use of brimonidine tartrate on the dark-adapted pupil diameter.
    American journal of ophthalmology, 2004, Volume: 138, Issue:1

    Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Brimonidine Tartrate; Dark Adaptation; Humans; Mydriasis; Ophthalmic Solutions; Pupil; Quinoxalines; Recurrence; Tachyphylaxis

2004
Acute and chronic effects of reserpine on biochemical and functional parameters of central and peripheral alpha 2-adrenoceptors.
    European journal of pharmacology, 1993, Aug-03, Volume: 239, Issue:1-3

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Binding Sites; Brain; Brimonidine Tartrate; Clonidine; Dihydroxyphenylalanine; Dioxanes; Idazoxan; Injections, Subcutaneous; Male; Mydriasis; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Reserpine; Tyrosine 3-Monooxygenase; Vas Deferens

1993
alpha(2)-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator.
    British journal of pharmacology, 2001, Volume: 134, Issue:4

    Topics: Adrenergic alpha-Antagonists; Aniline Compounds; Animals; Azepines; Binding, Competitive; Blood Pressure; Brimonidine Tartrate; Decerebrate State; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Contraction; Mydriasis; Piperidines; Quinoxalines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Vas Deferens; Vasodilator Agents; Yohimbine

2001